-
Evaluating the Effectiveness of FitterLife: A Community-Based Virtual Weight Management Program for Overweight Adults Without Diabetes or Hypertension in Singapore
Sep 9, 2025, 16:22 PM -
Transfusion-Related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective
Sep 9, 2025, 16:22 PM -
The HTA Landscape of Orphan Products in the UK Between 2019 and 2024
Sep 9, 2025, 16:22 PM -
Integrating Patient Perspectives in HTA: What Can We Learn to Inform HTA-Focused Value Communications?
Sep 9, 2025, 16:22 PM -
The Prevalence of COAs and DHTs for Studying Sleep Disorders in Clinical Trials
Sep 9, 2025, 16:22 PM -
First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema
Sep 9, 2025, 16:22 PM -
What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses
Sep 9, 2025, 16:22 PM -
Narrative Review of Total Quality-Adjusted Life Year (QALY) Gains From Oncology Medicines Reimbursed From 2020 To 2025 in Ireland
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL for Vasomotor Symptoms Caused by Endocrine Therapy: Reliability, Validity, and Differential Item Functioning
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Ireland
Sep 9, 2025, 16:22 PM -
The Alignment Between Technology Incorporations and Actual Health Needs
Sep 9, 2025, 16:22 PM -
Negotiated Closed Budgets in Greece: A Case Study of Success in Enhancing Patient Access Whilst Achieving Savings
Sep 9, 2025, 16:22 PM -
The Impact of Intravesical Instillations on Quality of Life in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
Sep 9, 2025, 16:22 PM -
Improvements in Scalp Outcomes With Roflumilast Foam 0.3% for Psoriasis of the Scalp and Body From the Phase 3 ARRECTOR Trial
Sep 9, 2025, 16:22 PM -
Integrating Real-World Evidence for Advanced Therapies in Inflammatory Bowel Disease Into Reimbursement Submissions: Insights and Considerations From the UK
Sep 9, 2025, 16:22 PM -
Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study
Sep 9, 2025, 16:22 PM -
Will Patient Input Shape EU-Level Health Technology Assessments? HTA Representative Perspectives on the EU HTA Regulation
Sep 9, 2025, 16:22 PM -
Climate Impact of CAR-T Cell Therapy in the Netherlands: A Comparison on the Use Phase Emission Between Standard of Care and CAR-T Cell Therapy in Hemato-oncology
Sep 9, 2025, 16:22 PM -
Impact on Prescribing Choice Following the Identification of Preferred Continuous Glucose Monitoring Sensors in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM
